Drug Type Small molecule drug |
Synonyms SA-58035, SAH-58035, SAN 58-035 + [2] |
Target |
Action inhibitors, agonists |
Mechanism ACAT1 inhibitors(acetyl-CoA acetyltransferase 1 inhibitors), ERs agonists(Estrogen receptors agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC30H47NOSi |
InChIKeyNBYATBIMYLFITE-UHFFFAOYSA-N |
CAS Registry78934-83-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | France | 11 Jul 2006 | |
Atherosclerosis | Preclinical | France | 11 Jul 2006 | |
Neoplasms | Preclinical | France | 11 Jul 2006 | |
Hyperlipidemias | Discovery | Switzerland | - |